Smith & Nephew SNATS (NYSE:SNN) Stock Price Crosses Above 200-Day Moving Average – Time to Sell?

Smith & Nephew SNATS, Inc. (NYSE:SNN) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $34.59 and traded as high as $35.33. Smith & Nephew SNATS shares last traded at $35.09, with a volume of 1,016,161 shares traded.

Analysts Set New Price Targets

Several brokerages recently commented on SNN. Wall Street Zen raised Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 10th. Kepler Capital Markets raised shares of Smith & Nephew SNATS to a “strong-buy” rating in a research report on Monday, November 17th. Sanford C. Bernstein set a $37.50 price target on Smith & Nephew SNATS and gave the stock a “market perform” rating in a research report on Tuesday, October 14th. Canaccord Genuity Group decreased their price target on Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a research note on Tuesday, November 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research note on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, Smith & Nephew SNATS currently has a consensus rating of “Hold” and a consensus target price of $35.75.

Smith & Nephew SNATS Stock Performance

The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60. The firm has a 50 day moving average price of $33.15 and a two-hundred day moving average price of $34.59.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in SNN. Garner Asset Management Corp bought a new stake in shares of Smith & Nephew SNATS in the 4th quarter worth about $27,000. Caitong International Asset Management Co. Ltd acquired a new position in Smith & Nephew SNATS in the third quarter valued at about $41,000. AlphaCore Capital LLC bought a new stake in Smith & Nephew SNATS during the second quarter worth about $44,000. Northwestern Mutual Wealth Management Co. increased its holdings in Smith & Nephew SNATS by 105.8% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 712 shares in the last quarter. Finally, Huntington National Bank raised its position in Smith & Nephew SNATS by 1,837.0% in the 3rd quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider’s stock valued at $51,000 after purchasing an additional 1,341 shares during the last quarter. 25.64% of the stock is owned by institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.